Potent, selective inhibitor of 5-lipoxygenase. Long half-life and high oral bioavailability in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma.
Payne et al.
Agents Actions Suppl., 1991;34:189
Inhibition of 5-lipoxygenase: development of hydroxamic acids and hydroxyureas as potential therapeutic agents.
Salmon et al.
Effect of BW B70C, a novel inhibitor of arachidonic acid 5-lipoxygenase, on allergen-induced bronchoconstriction and late-phase lung eosinophil accumulation in sensitised guinea-pigs.
Yeadon et al.
Agents Actions, 1993;38:8
The citations listed below are publications that use Tocris products. Selected citations for BW-B 70C include:
Showing Results 1 - 1 of 1